Invesco
RLMD icon

Invesco’s Relmada Therapeutics RLMD Stock Holding History

Invesco’s Portfolio RLMD Stock Details RLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$156K Buy
+22,442
New +$106K ﹤0.01% 3551
2022
Q4 		– Sell
-114,245
Closed -$4.23M – 4061
2022
Q3 		$4.23M Buy
114,245
+103,578
+971% +$2.87M ﹤0.01% 2318
2022
Q2 		$203K Buy
10,667
+1,545
+17% +$33.7K ﹤0.01% 3720
2022
Q1 		$247K Buy
+9,122
New +$189K ﹤0.01% 3718
2021
Q1 		– Sell
-267,155
Closed -$8.57M – 3934
2020
Q4 		$8.57M Buy
267,155
+2,190
+0.8% +$75.3K ﹤0.01% 1888
2020
Q3 		$9.97M Sell
264,965
-57,776
-18% -$2.23M ﹤0.01% 1654
2020
Q2 		$14.4M Buy
322,741
+56,623
+21% +$2.39M 0.01% 1433
2020
Q1 		$9.08M Sell
266,118
-3,119
-1% -$126K ﹤0.01% 1576
2019
Q4 		$10.5M Buy
+269,237
New +$8.18M ﹤0.01% 1738

Other funds holding RLMD

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $250M AUM
SSC
Spruce Street Capital New York $416M AUM
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return